Medrol Dosepak Taper for Delayed Post-op Recovery After TKA
Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of a methylprednisolone taper on patients with decreased range of
motion (ROM) or delayed recovery in the acute postoperative period following total knee
arthroplasty (TKA).
Patients with decreased ROM or delayed recovery six weeks to three months post-TKA will
improve ROM and patient-reported outcomes at two weeks post-treatment initiation of
methylprednisolone taper, as compared to similar patients who receive a placebo taper.